Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition:   Gastroenteritis NorovirusInterventions:   Other: Placebo;   Biological: Snow Mountain stool filtrateSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition:   Gastroenteritis NorovirusInterventions:   Biological: Snow Mountain stool filtrate;   Other: PlaceboSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition:   Gastroenteritis NorovirusInterventions:   Other: Placebo;   Biological: Snow Mountain stool filtrateSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition:   Gastroenteritis NorovirusInterventions:   Biological: Snow Mountain stool filtrate;   Other: PlaceboSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition:   Gastroenteritis NorovirusInterventions:   Other: Placebo;   Biological: Snow Mountain stool filtrateSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials

Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition:   Gastroenteritis NorovirusInterventions:   Biological: Snow Mountain stool filtrate;   Other: PlaceboSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials

Serologic Assay Validation, Proficiency Testing Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine
Condition:   NorovirusIntervention:   Biological: NoV GI.1/GII.4 Bivalent VLP VaccineSponsor:   TakedaActive, not recruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2015 Category: Research Source Type: clinical trials